• Emploi 0
  • Offres 0
  • Visites
  • FAQ
  • Nous contacter
  • Annuaire ITER
  • S'abonner

    Inscrivez-vous

    Votre adresse email ne sera utilisée que dans le cadre de campagnes d'information ITER Organization auxquelles vous êtes abonné. ITER Organization ne communiquera jamais votre adresse email et autres informations personnelles à quiconque ou dans le cadre d'informations commerciales.

    Si vous changez d'avis, il vous est possible de vous désinscrire en cliquant sur le lien 'unsubscribe' visible dans vos emails provenant d'ITER Organization.

    Pour plus d'information, veuillez consulter notre Politique de confidentialité.

    Choisissez ce que vous souhaitez recevoir :

  • Faire un don

Pour les actualités en français, voir la page News in French.

Nuclear Fusion Award winner announced

1 Nov 2006 - -
Winner of the inaugural Nuclear Fusion Award, Dr Timothy C. Luce (General Atomics), is presented with his award by Professor Werner Burkart (Deputy Director General, International Atomic Energy Agency) and Dr Mitsuru Kikuchi (Chairman of the Board of Editors, Nuclear Fusion and Director Division of Advanced Plasma Research, Japan Atomic Energy Agency) at the 21st IAEA fusion conference.

At the 21st IAEA Fusion Energy Conference in Chengdu, China, the lead author of a paper that demonstrates how one of the primary physics goals of ITER might be more safely realised was awarded the inaugural Nuclear Fusion Award, which is presented by the IAEA.

T.C. Luce et al. were awarded the prestigious prize for their paper 'Stationary high-performance discharges in the DIII-D tokamak' (Nuclear Fusion 43 (5), pp. 321-329). The paper outlines a tokamak scenario that can maintain high fusion performance at reduced plasma current (compared with the conventional tokamak operational scenario), thereby lessening the potential for structural damage in the event of a plasma disruption. Projections in the paper show that realization of this scenario in ITER could lead to fusion performance at or above an energy gain of 10 for longer duration with reduced risk.

Retourner vers les actualités